Results 121 to 130 of about 989 (143)

Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes. [PDF]

J Allergy Clin Immunol Glob
Kobayashi Y, Nakagomi D, Hanai S, Tran NQV, Nakamura Y, Matsuoka T, Sakurai D, Nakao A.   +7 more
europepmc   +1 more source

Knowledge, Attitudes, and Practices of Dermatologists on Chronic Pruritus and Its Management. [PDF]

Cureus
Talwar A, Shivhare S, Joshi DK, Gala M, Muchhala SS, Bhagat SV, Sanghavi A, Katare S, Kotak BP.   +8 more
europepmc   +1 more source

Syndrome of inappropriate antidiuretic hormone secretion following immune effector cell-associated neurotoxicity syndrome during blinatumomab therapy: a case report. [PDF]

J Pharm Health Care Sci
Yoshihara M, Yuyama S, Yasumuro O, Funakoshi R.   +3 more
europepmc   +1 more source

Comparing the effectiveness of four antihistamines with olopatadine in healthy Thoroughbred horses.

J Vet Med Sci
Ikeda Y, Kuroda T, Mita H, Tamura N, Ohta M.   +4 more
europepmc   +1 more source

Comparison of the Efficacy and Safety of Bilastine 20 mg vs Desloratadine 5 mg in Seasonal Allergic Rhinitis Patients

Allergy: European Journal of Allergy and Clinical Immunology, 2009
Bilastine is a novel, nonsedating H-1-antihistamine developed for symptomatic treatment of Allergic Rhinitis and Chronic Idiopathic Urticaria. The objective of this study was to compare the efficacy and safety of bilastine 20 mg vs placebo and ...
Paul Van de Heyning, Piotr Kuna, Claus Bachert   +2 more
exaly   +2 more sources

Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation [PDF]

Advances in Therapy, 2021
Bilastine is a second-generation H1 antihistamine indicated for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. On the basis of the demonstrated efficacy and safety of the oral formulation, a new ophthalmic formulation of ...
Francisco Abad-Santos, Gina Mejía, Samuel MARTIN VILCHEZ   +2 more
exaly   +2 more sources

Bilastine in Allergic Rhinoconjunctivitis and Urticaria

Allergy: European Journal of Allergy and Clinical Immunology, 2010
P>Allergic rhinoconjunctivitis and urticaria are increasing in prevalence in many developed countries. The role of histamine in such conditions is well documented and clinical guidelines recommend non-sedating H-1-receptor antagonists as first-line ...
Torsten Zuberbier, Piotr Kuna, Claus Bachert   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Identification and Synthesis of Potential Impurities of Bilastine Drug Substance

Chemical Papers, 2022
Purendar Reddy T, M Padma
exaly